Please sign in to follow a disease.
Herbal gel could boost gum disease treatment
NCT ID NCT07697209
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study tests whether a gel made from Centella asiatica (a herb) can improve standard treatment for gum disease. Adults with periodontitis receive either standard deep cleaning alone or cleaning plus the gel applied to the gums once a week for three months. Researchers measure gum health and antioxidant markers to see if the gel reduces inflammation and helps gums heal.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Centella asiatica nanoemulsion gel
- What this could lead to
- If effective, this gel could become a simple, natural add-on treatment to improve outcomes for people with gum disease.
- What could go wrong
- This is a small, early-stage trial with 45 participants, so results may not apply widely. The gel is tested as an add-on, not a standalone cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
45 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 25-55 years, either sex * Diagnosis of periodontal health OR Stage III periodontitis (per 2017 World Workshop Classification) Exclusion Criteria: * Known allergy or sensitivity to any component of the study medication * Systemic antibiotics or anti-inflammatory medications within the preceding 6 months * Uncontrolled diabetes mellitus * Cardiovascular disease * Rheumatoid arthritis * Renal disease * Pulmonary disease * Thyroid disease * Malignancy * Current smokers * Pregnant or lactating women * Unable or unwilling to comply with prescribed oral hygiene instructions
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periodontal bone loss are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
faculty of dentistry Mansoura university, Mansoura, 35516
Al Mansurah, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a pill replace an IV for gum surgery pain relief?
- Can everyday supplements boost gum disease therapy?
- Can pulling a loose tooth and putting it back save it?
- Gum fluid proteins eyed as link between smoking and periodontitis
- Gum fluid holds clues to Behçet's disease puzzle
- Magnifying the fight against gum disease: loupe vs microscope